Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Medical Microbiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ijmm.2009.08.006PMID 19828372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation

  2009cited by this paper
• Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance

  2009cited by this paper
• Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

  2009cited by this paper
• Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells

  2008cited by this paper
• Supernatant from Bifidobacterium Differentially Modulates Transduction Signaling Pathways for Biological Functions of Human Dendritic Cells

  2008cited by this paper
• Oral administration of probiotic bacteria (E. coli nissle,E. coli O83,Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice

  2008cited by this paper
• XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.

  2008cited by this paper
• VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

  2008cited by this paper
• Nutrient sensing and inflammation in metabolic diseases

  2008cited by this paper
• Innate immunity and intestinal microbiota in the development of Type 1 diabetes

  2008cited by this paper
• Colifagina, a Novel Preparation of 8 Lysed Bacteria Ameliorates Experimental Colitis

  2008cited by this paper
• Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization.

  2008cited by this paper
• Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• The genetics and immunopathogenesis of inflammatory bowel disease

  2008cited by this paper
• Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut

  2008cited by this paper
• Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

  2008cited by this paper
• Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis.

  2008cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2

  2008cited by this paper
• Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis

  2008cited by this paper
• Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve.

  2008cited by this paper
• Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background

  2007cited by this paper
• High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease

  2007cited by this paper
• Induction of Human β-Defensin 2 by the Probiotic Escherichia coli Nissle 1917 Is Mediated through Flagellin

  2007cited by this paper
• Intestinal epithelial cell proteome in IL-10 deficient mice and IL-10 receptor reconstituted epithelial cells: impact on chronic inflammation.

  2007cited by this paper
• Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammation.

  2007cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• Rapid and noninvasive metabonomic characterization of inflammatory bowel disease.

  2007cited by this paper
• The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells.

  2007cited by this paper
• Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity

  2007cited by this paper
• A Key Role of Dendritic Cells in Probiotic Functionality

  2007cited by this paper
• The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-41

  2007cited by this paper
• Translational Inhibition of Colonic Epithelial Heat Shock Proteins by IFN-γ and TNF-α in Intestinal Inflammation

  2007cited by this paper
• Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease.

  2007cited by this paper
• The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.

  2007cited by this paper
• CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.

  2007cited by this paper
• Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis

  2007cited by this paper
• Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia

  2007cited by this paper
• Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites

  2007cited by this paper
• High-Dose Probiotics for the Treatment of Active Pouchitis

  2007cited by this paper
• Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair

  2007cited by this paper
• Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.

  2007cited by this paper
• Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats.

  2007cited by this paper
• Effects of the Probiotic Formulation VSL#3 on Colitis in Weanling Rats

  2007cited by this paper
• Nonpathogenic Escherichia coli Strain Nissle 1917 Inhibits Signal Transduction in Intestinal Epithelial Cells

  2007cited by this paper
• Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease

  2006cited by this paper
• Mitochondria and calpains mediate caspase-dependent apoptosis induced by doxycycline in HeLa cells

  2006cited by this paper
• Endoplasmic reticulum stress in health and disease.

  2006cited by this paper
• Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.

  2006cited by this paper
• Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways

  2006cited by this paper
• The B-cell system in inflammatory bowel disease.

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease

  2006cited by this paper
• Inhibition of Ca2+ Influx Is Required for Mitochondrial Reactive Oxygen Species-Induced Endoplasmic Reticulum Ca2+ Depletion and Cell Death in Leukemia Cells

  2006cited by this paper
• Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis

  2006cited by this paper
• Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium‐induced colitis

  2006cited by this paper
• Anti‐Interferon‐inducible Chemokine, CXCL10, Reduces Colitis by Impairing T Helper‐1 Induction and Recruitment in Mice

  2005cited by this paper
• Nonpathogenic Escherichia coli Strain Nissle1917 Prevents Murine Acute and Chronic Colitis

  2005cited by this paper
• Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

  2005cited by this paper
• Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases

  2005cited by this paper
• Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor–κB activation in muramyl dipeptide recognition

  2005cited by this paper
• Probiotic Therapy in the Prevention of Pouchitis Onset: Decreased Interleukin‐1&bgr;, Interleukin‐8, and Interferon‐&ggr; Gene Expression

  2005cited by this paper
• Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

  2005cited by this paper
• Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells1

  2005cited by this paper
• Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

  2005cited by this paper
• Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.

  2005cited by this paper
• VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

  2005cited by this paper
• Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn’s disease

  2005cited by this paper
• Reduced Paneth cell α-defensins in ileal Crohn's disease

  2005cited by this paper
• Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

  2005cited by this paper
• Asthma and allergy: Pollen found guilty

  2005cited by this paper
• The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice.

  2005cited by this paper
• The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.

  2004cited by this paper
• Modulation of human dendritic cell phenotype and function by probiotic bacteria

  2004cited by this paper
• Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis

  2004cited by this paper
• Effects of probiotic on intestinal mucosa of patients with ulcerative colitis.

  2004cited by this paper
• Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

  2004cited by this paper
• Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis

  2004cited by this paper
• Delay of the First Onset of Pouchitis by Oral Intake of the Probiotic Strain Lactobacillus rhamnosus GG

  2004cited by this paper
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition.

  2004cited by this paper
• Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

  2004cited by this paper
• NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium

  2004cited by this paper
• Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

  2004cited by this paper
• DNA from probiotic bacteria modulates murine and human epithelial and immune function.

  2004cited by this paper
• A pilot trial of Saccharomyces boulardii in ulcerative colitis

  2003cited by this paper
• Randomized Controlled Trial of the Effect of Bifidobacteria-Fermented Milk on Ulcerative Colitis

  2003cited by this paper
• The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.

  2003cited by this paper
• Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

  2003cited by this paper
• Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model

  2002cited by this paper
• Variable Response to Probiotics in Two Models of Experimental Colitis in Rats

  2002cited by this paper
• Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment

  2001cited by this paper
• Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

  2001cited by this paper
• Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease

  2000cited by this paper
• Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial

  2000cited by this paper
• Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis

  1999cited by this paper
• Signal transduction from the endoplasmic reticulum to the cell nucleus.

  1999cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.

  1997cited by this paper

• Is Obesity a Modifiable Risk Factor in Multiple Sclerosis? Mechanistic Insights into Neuroinflammation and Oxidative Damage

  2026cites this paper
• Effects of the oral probiotic Familact on dyspnea management in COPD patients: A randomized controlled trial.

  2025cites this paper
• Gut Microbiota in Chronic Inflammatory Diseases - Literature Review

  2025cites this paper
• Gut microbiome metabolites in lung cancer: The emerging importance of short-chain fatty acids.

  2025cites this paper
• Exploration of novel bioactive compounds from the microbiome of fish and shellfish as an alternative to replace antibiotic drugs in aquaculture farming

  2025cites this paper
• Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review

  2024cites this paper
• Genome Investigation and Functional Annotation of Lactiplantibacillus plantarum YW11 Revealing Streptin and Ruminococcin-A as Potent Nutritive Bacteriocins against Gut Symbiotic Pathogens

  2023cites this paper
• Studies on exploring the potentials of gut microbiomes to mitigate the bacterial and viral diseases of fish and shellfish in aquaculture farming

  2023cites this paper
• Host-microbiome interaction in fish and shellfish: An overview.

  2023cites this paper
• Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study

  2023cites this paper
• Multiple sclerosis and obesity: The role of adipokines

  2022cites this paper
• The Lactobacillus as a Probiotic: Focusing on Liver Diseases

  2022cites this paper
• Bifidobacterium bifidum BGN4 Paraprobiotic Supplementation Alleviates Experimental Colitis by Maintaining Gut Barrier and Suppressing Nuclear Factor Kappa B Activation Signaling Molecules

  2022cites this paper
• Salinity significantly affects intestinal microbiota and gene expression in striped catfish juveniles

  2022cites this paper
• Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents

  2022cites this paper
• Gut microbiota and brain function and pathophysiology

  2021cites this paper
• The Role of Gut and Lung Microbiota in Susceptibility to Tuberculosis

  2021cites this paper
• Microplastics as an aquatic pollutant affect gut microbiota within aquatic animals.

  2021cites this paper
• S-layer protein modulates the stimulatory effects of Lactobacillus acidophilus CICC 6074 by triggering PKC signaling cascade in RAW 264.7 cells

  2020cites this paper
• Bugs as Drugs-Trends in Biotechnology

  2019cites this paper
• Functional capabilities of probiotic strains on attenuation of intestinal epithelial cell inflammatory response induced by TLR4 stimuli

  2018cites this paper
• Juçara (Euterpe edulis) pulp as a substrate for probiotic bacteria fermentation: Optimisation process and antioxidant activity

  2018cites this paper
• Anti-inflammatory activity of surface layer protein SlpA of Lactobacillus acidophilus CICC 6074 in LPS-induced RAW 264.7 cells and DSS-induced mice colitis

  2018cites this paper
• The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health.

  2018cites this paper
• Effects of dietary supplementation of Lactobacillus Plantarum on survival, hematological profile and histopathology of selected organs of Clarias gariepinus fingerlings

  2017cites this paper
• Role of nanotechnology in enhancing bioavailability and delivery of dietary factors

  2017cites this paper
• Role of the Intestinal Immune System in Health

  2017cites this paper
• Anti-inflammatory effect of lactic acid bacteria isolated from kimchi on acid-induced acute colitis in model mice

  2017cites this paper
• Does Short-Term High Dose Probiotic Supplementation Containing Lactobacillus casei Attenuate Exertional-Heat Stress Induced Endotoxaemia and Cytokinaemia?

  2016cites this paper
• Lactobacillus acidophilus alleviates the inflammatory response to enterotoxigenic Escherichia coli K88 via inhibition of the NF-κB and p38 mitogen-activated protein kinase signaling pathways in piglets

  2016cites this paper
• The evidence for microbiome manipulation in inflammatory arthritis.

  2016cites this paper
• Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice

  2016cites this paper
• Running title : Koch ’ s postulates for IBD 1 2 3

  2016cites this paper
• Koch's postulates, microbial dysbiosis and inflammatory bowel disease.

  2016cites this paper
• A Microbial Feed Additive Abates Intestinal Inflammation in Atlantic Salmon

  2015cites this paper
• Modulation of acute phase parameters of inflammation by probiotics in albino rats

  2015cites this paper
• Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.

  2015cites this paper
• Lactobacillus paracasei CNCM I-4034 and its culture supernatant modulate Salmonella-induced inflammation in a novel transwell co-culture of human intestinal-like dendritic and Caco-2 cells

  2015cites this paper
• Effect of body composition intake with nano-lactic acid in rats

  2015cites this paper
• [Characterization, influence and manipulation of the gastrointestinal microbiota in health and disease].

  2015cites this paper
• The effect of probiotics on immune regulation, acne, and photoaging

  2015cites this paper
• Effects of Rhubarb on Intestinal Flora and Toll-Like Receptors of Intestinal Mucosa in Rats With Severe Acute Pancreatitis

  2015cites this paper
• Antibodies to Lactobacilli and Bifidobacteria in Young Children with Different Propensity to Develop Islet Autoimmunity

  2014cites this paper
• Intestinal Microbiota: Its Role in Digestive Diseases

  2014cites this paper
• Effects of Chitosan on Intestinal Inflammation in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli

  2014cites this paper
• Probiotics, prebiotics, synbiotics in prevention and treatment of inflammatory bowel diseases

  2014cites this paper
• Immunomodulation of Antiretroviral Drug-Suppressed Chronic HIV-1 Infection in an Oral Probiotic Double-Blind Placebo-Controlled Trial

  2014cites this paper
• Role of Toll-Like Receptor 4 in Colorectal Carcinogenesis: A Meta-Analysis

  2014cites this paper
• Animal models of human disease: inflammation.

  2014cites this paper
• Biofunctionality of Sourdough Metabolites in Healthy and Inflamed Gastrointestinal Tract

  2014cites this paper
• The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models

  2014cites this paper
• [Current view on gut microbiota].

  2014cites this paper
• Gastrointestinal Tract: Microflora and Transit Aspects

  2014cites this paper
• Actualité du microbiote intestinal

  2014cites this paper
• Probiotics in the Management of Lung Diseases

  2013cites this paper
• Nutritional protective mechanisms against gut inflammation.

  2013influential citation
• REVIEWS: CURRENT TOPICS Nutritional protective mechanisms against gut inflammation☆

  2013influential citation
• Mucosal immunity in a healthy gut.

  2013cites this paper
• Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target

  2013cites this paper
• Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease

  2013cites this paper
• C URRENT OPINION Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target

  2013cites this paper
• Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa

  2013cites this paper
• Role of “Western Diet” in Inflammatory Autoimmune Diseases

  2013cites this paper
• Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli

  2013cites this paper
• Anti‐inflammatory properties of dairy lactobacilli

  2012cites this paper
• Butyrate Attenuates Lipopolysaccharide-Induced Inflammation in Intestinal Cells and Crohn's Mucosa through Modulation of Antioxidant Defense Machinery

  2012cites this paper
• Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines.

  2012cites this paper
• Apple polyphenols extract (APE) improves colon damage in a rat model of colitis.

  2012cites this paper
• Nutritional and Probiotic Supplementation in Colitis Models

  2012influential citation
• Cellular alterations of mucosal integrity by ribotoxins: mechanistic implications of environmentally-linked epithelial inflammatory diseases.

  2012cites this paper
• Analytical strategies for characterization and validation of functional dairy foods

  2012cites this paper
• Colonic expression of the intestinal peptide transporter PEPT1 is not associated with inflammatory bowel diseases in humans and mouse models

  2012cites this paper
• The Intestinal Immune System in Health

  2012cites this paper
• Molecular analysis of candidate probiotic effector molecules of Lactobacillus plantarum

  2012cites this paper
• La relation hôte-microbiote dans le développement du diabète de type 2 : du mutualisme au parasitisme métabolique

  2012cites this paper
• Conjugated linoleic acid

  2012cites this paper
• Inflammatory bowel disease: role of diet, microbiota, life style.

  2012influential citation
• Probiotics and immune response regulation: allergics diseases and guts inflammations effects

  2011cites this paper
• Environmental influences on T regulatory cells in inflammatory bowel disease.

  2011cites this paper
• Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers

  2011cites this paper
• Adenosine in the inflamed gut: a Janus faced compound.

  2011cites this paper
• Probiotiques et régulation de la réponse immunitaire: impact sur les maladies allergiques et les maladies inflammatoires intestinales

  2011influential citation
• Island biogeography effects on microbial evolution may contribute to Crohn's disease.

  2011cites this paper
• An intimate tête-à-tête - how probiotic lactobacilli communicate with the host.

  2011cites this paper
• Differential Targeting of the E-Cadherin/β-Catenin Complex by Gram-Positive Probiotic Lactobacilli Improves Epithelial Barrier Function

  2011cites this paper
• Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells

  2011cites this paper
• Mechanisms controlling pathogen colonization of the gut.

  2011cites this paper
• Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis.

  2011cites this paper
• The impact of perinatal immune development on mucosal homeostasis and chronic inflammation

  2011cites this paper
• Nutritional modulation of intestinal inflammation

  2011cites this paper
• Review: The use of direct fed microbials to mitigate pathogens and enhance production in cattle

  2011cites this paper
• Immunobiotic Lactobacillus jensenii Elicits Anti-Inflammatory Activity in Porcine Intestinal Epithelial Cells by Modulating Negative Regulators of the Toll-Like Receptor Signaling Pathway

  2011cites this paper
• The Role of Pre- and Probiotics in the Treatment of Inflammatory Bowel

  2011cites this paper
• Aberrant response to commensal Bacteroides thetaiotaomicron in Crohn's disease: An ex vivo human organ culture study

  2011influential citation
• Transit Time Affects the Community Stability of Lactobacillus and Bifidobacterium Species in an In Vitro Model of Human Colonic Microbiotia

  2011cites this paper
• Key questions to guide a better understanding of host–commensal microbiota interactions in intestinal inflammation

  2011cites this paper
• The gut as communicator between environment and host: immunological consequences.

  2011cites this paper
• The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

  2011cites this paper
• Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism.

  2010cites this paper
• Probiotics in the management of children with allergy and other disorders of intestinal inflammation.

  2010cites this paper